Compare IVA & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVA | EQBK |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | France | United States |
| Employees | 77 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.8M | 993.2M |
| IPO Year | N/A | 2015 |
| Metric | IVA | EQBK |
|---|---|---|
| Price | $4.60 | $51.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $16.20 | ★ $51.33 |
| AVG Volume (30 Days) | ★ 1.7M | 161.8K |
| Earning Date | 03-30-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $74.58 |
| Revenue Next Year | $751.20 | $5.11 |
| P/E Ratio | ★ N/A | $61.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $36.04 |
| 52 Week High | $7.98 | $51.48 |
| Indicator | IVA | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 60.58 | 70.91 |
| Support Level | $4.45 | $43.99 |
| Resistance Level | $4.69 | N/A |
| Average True Range (ATR) | 0.31 | 1.33 |
| MACD | 0.12 | 0.11 |
| Stochastic Oscillator | 88.85 | 96.04 |
Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.